Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RSMDF) Net Margin (2016 - 2025)

Historic Net Margin for Resmed (RSMDF) over the last 17 years, with Q4 2025 value amounting to 27.59%.

  • Resmed's Net Margin rose 7100.0% to 27.59% in Q4 2025 from the same period last year, while for Dec 2025 it was 27.53%, marking a year-over-year increase of 21800.0%. This contributed to the annual value of 27.22% for FY2025, which is 54300.0% up from last year.
  • According to the latest figures from Q4 2025, Resmed's Net Margin is 27.59%, which was up 7100.0% from 26.1% recorded in Q3 2025.
  • In the past 5 years, Resmed's Net Margin ranged from a high of 28.26% in Q1 2025 and a low of 10.21% during Q1 2021
  • For the 5-year period, Resmed's Net Margin averaged around 21.68%, with its median value being 22.4% (2021).
  • Its Net Margin has fluctuated over the past 5 years, first crashed by -314100bps in 2021, then skyrocketed by 309200bps in 2022.
  • Over the past 5 years, Resmed's Net Margin (Quarter) stood at 22.55% in 2021, then decreased by -3bps to 21.76% in 2022, then dropped by -17bps to 17.96% in 2023, then soared by 50bps to 26.88% in 2024, then increased by 3bps to 27.59% in 2025.
  • Its last three reported values are 27.59% in Q4 2025, 26.1% for Q3 2025, and 28.17% during Q2 2025.